Trial Profile
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drug
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2014
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 05 Dec 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 May 2012 New trial record